Jinyu Bio-Technology Co (SHSE:600201) Beginning Cash Position: ¥591 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600201 Jinyu Bio-Technology Co Ltd SHSE:600201
63 GF Score
Price ¥13.64
GF Value ¥8.91
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Jinyu Bio-Technology Co Beginning Cash Position?

Jinyu Bio-Technology Co SHSE:600201 -0.80% 63 Beginning Cash Position is ¥591 Mil as of Jun. 2026. GuruFocus rates SHSE:600201 with a GF Score™ of 63/100 and a GF Value™ of ¥8.91 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Jinyu Bio-Technology Co's Beginning Cash Position for the quarter that ended in Jun. 2026 was ¥591 Mil.

Jinyu Bio-Technology Co's quarterly Beginning Cash Position declined from Dec. 2025 (¥857 Mil) to Mar. 2026 (¥617 Mil) and declined from Mar. 2026 (¥617 Mil) to Jun. 2026 (¥591 Mil).

Jinyu Bio-Technology Co's annual Beginning Cash Position declined from Dec. 2023 (¥1,267 Mil) to Dec. 2024 (¥1,053 Mil) and declined from Dec. 2024 (¥1,053 Mil) to Dec. 2025 (¥814 Mil).

Jinyu Bio-Technology Co Beginning Cash Position Related Terms

Jinyu Bio-Technology Co Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Jinyu Bio-Technology Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jinyu Bio-Technology Co Beginning Cash Position Chart

Jinyu Bio-Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,320.99 1,182.59 1,266.66 1,052.76 813.92

Jinyu Bio-Technology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 691.37 758.56 857.25 616.75 591.43
SHSE:600201
63GF Score
Jinyu Bio-Technology Co Ltd SHSE:600201
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jinyu Bio-Technology Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of ¥591 Mil mean?
Jinyu Bio-Technology Co (SHSE:600201) has a Beginning Cash Position of ¥591 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Jinyu Bio-Technology Co and its competitors.
Is Jinyu Bio-Technology Co's Beginning Cash Position too high?
Jinyu Bio-Technology Co's current Beginning Cash Position is ¥591 Mil. Overall, Jinyu Bio-Technology Co has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jinyu Bio-Technology Co's Beginning Cash Position compare to VRTX and REGN?
Jinyu Bio-Technology Co's Beginning Cash Position of ¥591 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Jinyu Bio-Technology Co and its competitors. Jinyu Bio-Technology Co's current Beginning Cash Position is ¥591 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinyu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co (SHSE:600201) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥8.91, compared to a current price of ¥13.64 — trading 53.1% above its estimated fair value. The current Beginning Cash Position is ¥591 Mil. Jinyu Bio-Technology Co's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Jinyu Bio-Technology Co (SHSE:600201), the current Beginning Cash Position is ¥591 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jinyu Bio-Technology Co (SHSE:600201) Overvalued in 2026?

Based on GuruFocus' analysis, Jinyu Bio-Technology Co stock appears to be overvalued. The current stock price of ¥13.64 is trading 53.1% above its estimated GF Value™ of ¥8.91. GuruFocus considers Jinyu Bio-Technology Co to be Significantly Overvalued.

Key valuation signals for SHSE:600201:

  • Beginning Cash Position: ¥591 Mil
  • GF Value™: ¥8.91 vs. price of ¥13.64 (53.1% above fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jinyu Bio-Technology Co Business Description

Address No.1, Jinyu Street, Shaeryu Industrial Park, Economic and Technological Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010030
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
63GF Score

Get the complete analysis for SHSE:600201

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥13.64
Price
¥8.91
GF Value